Buyers often reach plant-derived extracellular vesicles (EVs, usually sold as exosomes) for one reason: a provider wants to avoid human-derived material. That is a legitimate starting point. It is not enough to choose a supplier, because "plant exosome" describes a category, not a product.
First, what you are buying
EVs are not cells. They are nanoscale, membrane-bound particles that cells release, roughly the size of a virus, carrying proteins, lipids and nucleic acids inside and on their surface. Plant and human EVs share that basic architecture. Their cargo differs: human mesenchymal stem cell EVs carry human signalling molecules, while plant EVs carry plant proteins, some of which act on similar pathways, such as antioxidant and inflammation-related ones. The plant versus mammalian comparison covers the science in more depth.
Because the cargo depends on the source and on how the vesicles were made, two plant-derived products, even from the same species, cannot be assumed to be equivalent. The questions below are how you find out.
The ten questions
1. Which plant, and which part of it?
"Plant-derived" is not specific. Look for the species and the tissue, for example Aloe barbadensis leaf. Different species and tissues carry different cargo.
2. Which isolation method family is used?
Isolation shapes what the product is. Ultracentrifugation, the most common method in the field, can strip the loosely associated layer of biomolecules on the vesicle surface, the biomolecular corona, which contributes to how vesicles interact with cells. Published comparisons, including our founder's work, show that isolation methods differentially change the corona's composition and functionality. A supplier does not need to disclose a proprietary process in full, but it should name the method family and offer more detail under a confidentiality agreement.
3. What is the particle concentration, and how was it measured?
Ask for particles per millilitre and per vial, measured by Nanoparticle Tracking Analysis (NTA) or an equivalent named method, with a size distribution. A product with no particle count cannot be dosed or compared.
4. Is the Certificate of Analysis batch-specific?
A Certificate of Analysis should belong to the batch in the vial, not a "representative lot". It should report results, not just specifications.
5. What does the Certificate of Analysis actually test?
Expect particle concentration and size, a purity indicator such as particle-to-protein ratio, pH, and microbial testing appropriate to the intended use. For anything beyond intact skin, ask about sterility and endotoxin, covered in detail in topical, microneedling or injectable.
6. Who performs the testing?
In-house testing is normal in a young field, and it can be rigorous. Third-party testing adds independent confirmation. Ask which applies, and whether the methods follow the MISEV2023 reporting framework.
7. What is the product made and labelled for?
A cosmetic is for intact skin. Research-grade material is for laboratory research. Microneedling and injection require products authorized for those uses. The label and the Certificate of Analysis should say which one you are buying.
8. What format is it, and how is it stored?
Liquid, frozen and lyophilized (freeze-dried) products behave very differently. Ask for storage temperature, shelf life and the data behind it, and how long the product keeps after opening or reconstitution. See freeze-dried EVs and storage.
9. Can the supplier make it consistently?
Ask how batch-to-batch consistency is measured, for example the variation in particle-to-protein ratio between batches, and whether the process is designed to scale. One good batch is not a supply.
10. How do you actually buy it?
Some manufacturers sell material directly. Others supply only through licensed brands or distributors. Ask who sells to you, under which terms, and who is responsible for the finished product's claims.
How BioThera answers these questions
For transparency, here is how BioThera answers the same list today:
- Source: Aloe barbadensis leaf.
- Isolation: a proprietary, patent-pending process built on gentle processing steps that avoid mechanical or chemical damage to the vesicles; process details are available to qualified partners under confidentiality agreement.
- Particle concentration: measured by NTA on every batch, with size distribution, and reported on its Certificate of Analysis.
- Certificate of Analysis: batch-specific, covering particle concentration and size, particle-to-protein ratio, pH, microbial counts, mycoplasma and endotoxin (reported). Sample Certificates of Analysis are sent by email on request.
- Testing: performed in-house, in line with MISEV2023. BioThera is selecting a third-party laboratory to independently validate the testing behind its Certificate of Analysis.
- Intended use: topical cosmetic use; not for injection or microneedling. Research-grade material is available separately for laboratories.
- Format: lyophilized, stored at room temperature, 5-year shelf life; after reconstitution, up to 1 month at 4 °C or up to 1 year frozen.
- Consistency: particle-to-protein ratio variation is tracked within and between batches, and the process is designed to scale.
- How to buy: for cosmetic use, through Vesera™, a skincare company and BioThera subsidiary that holds the exclusive cosmetic licence and handles distribution. For research-grade material and partnerships outside cosmetics, through BioThera directly.
The implication
Choosing plant over human material narrows the field. It does not choose the supplier. The supplier worth choosing is the one that answers all ten questions specifically, in writing, before you ask twice.
